We are celebrating 21 years in Business - Thank You For Making Us The #1 Go To Site for Your Health Care

hematology, medical oncology, oncology review course, board review, recalled oncology questions, breast cancer, radiation, bone, cervix, breast, lymphoma, oncology, pediatrics, breast surgery, colon, hydrotherapy, prostate, prostate cancer, oncology board review questions, bladder, bone tumors, bladder, wilms tumor, hematology, colon, testicular, radiation therapy, radiation treatment, colon cancer, skin, carcinoma, endometrium, bone marrow, bone cancer, tumors, radiation, bone tissue, breast cancer, skin diseases, gynecology, rhabdo, myosarcoma, whole body radiation, hyperfractionation, head neck, thymomas, mediastinal masses, cns tumors, esophagus, renal carcinoma, desmoid tumor of the abdominal wall, neuro, radiation oncology, google, comprehensive board review, devita, hellman, rosenbergs cancer, e-book, e-books, Amazon Kindle, Palm, mobipocket, pda books, PDF, Iliad, DRM-free, Palm DOC, RTF, EPUB

Medical-technology-news

The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

  • Study of California kidney cancer shows declining incidence, end of a trend August 18, 2017
    A study of kidney cancer incidence in California over 25 years is the first report to demonstrate that the rising rate of kidney cancer seen in the US over the past two decades may have ended.
  • Histone 1, the guardian of genome stability August 18, 2017
    Genomic instability is the main risk factor for tumor development in humans. Therefore understanding its origin and and exploring therapeutic targets is paramount. Histone 1 silences a region of the genome that causes irreparable DNA damage when translated and is lethal for the organism.
  • A better way to measure mortality trends? August 17, 2017
    A new study suggests long-term mortality trends may be better understood by focusing on life-years lost -- remaining life expectancy for a decedent -- instead of solely looking at cause of death.
  • Gold nanostars and immunotherapy vaccinate mice against cancer August 17, 2017
    By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked satellite tumors and distant cancerous cells, completely curing two mice and effectively vaccinating one against the disease.
  • New terahertz imaging approach could speed up skin cancer detection August 17, 2017
    Researchers have developed a new terahertz imaging approach that, for the first time, can acquire micron-scale resolution images while retaining computational approaches designed to speed up image acquisition.
  • New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine August 17, 2017
    A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns of individual cancers observed in the study strongly reinforces the need for personalized cancer treatment based on precision medicin […]
  • Vitamin C may encourage blood cancer stem cells to die August 17, 2017
    Vitamin C may 'tell' faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers.

CancerGroup.com